輸入代號或公司名稱後按 Enter
4190

佐登-KY

-0.10 (-0.39%)最後更新 2026-09-11
台灣 · 上市 · 生技醫療業
25.8512成交張數本益比0.95股價淨值比1.93%殖利率2026-09-11資料日期

每股盈餘

柱為單季 EPS,線為近四季合計;近十年

季度單季 EPS年增近四季 EPS歸屬母公司淨利(億)淨利率ROE(季)ROE(近四季)
2026Q2-0.80-1.42-0.47-8.9%-2.92%-5.31%
2026Q1-0.26-1.39-0.16-2.9%-0.96%-4.93%
2025Q40.21-1.590.121.9%0.77%-5.53%
2025Q3-0.57-2.40-0.34-6.1%-2.16%-8.29%
2025Q2-0.77-3.44-0.46-8.8%-2.78%-11.93%
2025Q1-0.46-3.81-0.27-4.5%-1.54%-12.33%
2024Q4-0.60-4.87-0.36-6.3%-1.96%-15.17%
2024Q3-1.61-4.44-0.97-16.9%-5.13%-13.24%
2024Q2-1.14-246.2%-3.53-0.68-11.8%-3.56%-10.50%
2024Q1-1.52-1788.9%-1.61-0.92-16.3%-4.55%-4.76%
2023Q4-0.170.00-0.11-1.5%-0.50%-0.01%
2023Q3-0.70-0.10-0.42-6.2%-1.94%-0.26%
2023Q20.7832.2%0.360.475.8%2.20%1.01%
2023Q10.09-43.8%0.170.050.7%0.24%0.46%
2022Q4-0.27-117.2%0.24-0.16-1.9%-0.74%0.63%
2022Q3-0.24-138.7%2.08-0.14-2.2%-0.66%5.68%
2022Q20.59-62.4%2.940.355.5%1.62%8.11%
2022Q10.16-86.9%3.920.091.4%0.41%10.70%
2021Q41.57-32.0%4.980.9311.8%4.19%13.42%
2021Q30.62-57.5%5.720.365.7%1.71%16.56%
2021Q21.5774.4%6.560.9213.7%4.34%19.78%
2021Q11.225.890.719.8%3.39%16.69%
2020Q42.31-16.0%4.411.3516.2%6.80%12.59%
2020Q31.46-4.0%4.850.8611.8%4.65%15.04%
2020Q20.90-65.5%4.910.538.3%2.79%15.82%
2020Q1-0.26-122.2%6.62-0.15-2.8%-0.77%19.49%
2019Q42.7512.7%8.051.6117.7%8.27%24.22%
2019Q31.52-28.2%7.740.8811.3%4.77%25.52%
2019Q22.611.9%8.341.5317.1%8.01%28.39%
2019Q11.17-38.5%8.290.6910.3%3.57%27.08%
2018Q42.44265.5%9.021.4317.1%8.06%31.71%
2018Q32.12146.9%7.251.2315.8%7.51%27.38%
2018Q22.56277.9%5.991.5018.8%9.40%23.96%
2018Q11.90109.9%4.111.1216.1%7.30%15.59%
2017Q40.67-53.5%3.110.396.0%2.70%12.43%
2017Q30.86-26.5%3.880.518.4%3.66%16.25%
2017Q20.68-35.2%4.180.407.1%2.81%18.28%
2017Q10.91-9.0%4.550.5310.6%3.58%17.32%
2016Q41.434.640.8414.8%5.88%
2016Q31.170.6815.2%5.00%